Watch for Toxicities From Immune Checkpoint Inhibitors

You’ll get questions about adverse effects with immune checkpoint inhibitors (ICIs) as use increases.

Immune checkpoint inhibitors, such as pembrolizumab (Keytruda) or nivolumab (Opdivo), are a common type of cancer immunotherapy.

Cancer immunotherapy works by helping the patient’s immune system find and kill cancer cells. It’s different from chemotherapy, which directly targets dividing cells...malignant or healthy.